Tudor Investment Corp ET AL decreased its holdings in Enhabit, Inc. (NYSE:EHAB - Free Report) by 24.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 229,191 shares of the company's stock after selling 74,355 shares during the quarter. Tudor Investment Corp ET AL owned approximately 0.45% of Enhabit worth $1,836,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the business. Verition Fund Management LLC bought a new position in Enhabit in the 3rd quarter valued at $228,000. Mercer Global Advisors Inc. ADV bought a new position in Enhabit in the 3rd quarter valued at $95,000. Bank of America Corp DE raised its position in Enhabit by 73.3% in the 3rd quarter. Bank of America Corp DE now owns 687,934 shares of the company's stock valued at $5,510,000 after purchasing an additional 290,978 shares during the last quarter. 8 Knots Management LLC raised its position in Enhabit by 9.5% in the 3rd quarter. 8 Knots Management LLC now owns 4,218,846 shares of the company's stock valued at $33,793,000 after purchasing an additional 365,779 shares during the last quarter. Finally, Algert Global LLC raised its position in Enhabit by 1,131.2% in the 3rd quarter. Algert Global LLC now owns 222,609 shares of the company's stock valued at $1,783,000 after purchasing an additional 204,529 shares during the last quarter.
Analyst Upgrades and Downgrades
EHAB has been the subject of several research analyst reports. Weiss Ratings reiterated a "sell (e+)" rating on shares of Enhabit in a research report on Monday, December 29th. TD Cowen restated a "hold" rating and set a $13.80 target price (up from $12.00) on shares of Enhabit in a research report on Friday, March 6th. Leerink Partners boosted their target price on Enhabit from $9.50 to $13.80 and gave the stock a "market perform" rating in a research report on Monday, February 23rd. Deutsche Bank Aktiengesellschaft upgraded Enhabit to a "buy" rating in a research report on Tuesday, January 13th. Finally, Truist Financial set a $13.80 target price on Enhabit in a research report on Monday, February 23rd. Two investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $13.57.
View Our Latest Report on EHAB
Enhabit Trading Up 0.0%
EHAB stock opened at $13.98 on Monday. The company has a market cap of $709.27 million, a P/E ratio of -155.38 and a beta of 1.45. Enhabit, Inc. has a twelve month low of $6.47 and a twelve month high of $14.22. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76. The business has a fifty day moving average of $12.94 and a 200-day moving average of $10.41.
Enhabit (NYSE:EHAB - Get Free Report) last released its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, hitting analysts' consensus estimates of $0.14. The company had revenue of $270.40 million during the quarter, compared to the consensus estimate of $270.56 million. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%. As a group, equities research analysts expect that Enhabit, Inc. will post 0.22 EPS for the current year.
Insider Buying and Selling
In related news, EVP Julie Diane Jolley sold 2,793 shares of the company's stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $13.63, for a total value of $38,068.59. Following the completion of the sale, the executive vice president owned 139,923 shares in the company, valued at approximately $1,907,150.49. This represents a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 3.40% of the company's stock.
About Enhabit
(
Free Report)
Enhabit, Inc NYSE: EHAB is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Featured Articles
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enhabit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.
While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.